Furthermore, previous studies have shown over-expression of dynamin 2 in pancreatic, prostate, and cervical cancers (Eppinga et al., 2012[6]; Xu et al., 2014[42]; Lee et al., 2016[25]). Here, DNM2 is linked to cervical cancer.